Large-Scale Health System Study Launches: Data-Driven OUD Screening and Treatment Integration — Implementation Science for Australian Healthcare

References

1. 1.Australian Government Department of Health. (2023). Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Dependence. Australian Government Publishing. https://www.health.gov.au/resources/publications/clinical-guidelines-for-the-use-of-buprenorphine-in-the-treatment-of-opioid-dependence
2. 2.Connery, H. S. (2015). Medication-assisted treatment of opioid use disorder: review of the evidence and future directions. Harvard Review of Psychiatry, 23(2), 63-75. https://doi.org/10.1097/HRP.0000000000000075
3. 3.Hadland, S. E., Bagley, S. M., Rodean, J., Silverstein, M., Levy, S., Larochelle, M. R., Samet, J. H., & Shah, S. S. (2018). Receipt of timely addiction treatment and association of early medication treatment with retention in care among youths with opioid use disorder. JAMA Pediatrics, 172(11), 1029-1037. https://doi.org/10.1001/jamapediatrics.2018.2143
4. 4.Hawk, K. F., Vaca, F. E., & D'Onofrio, G. (2015). Reducing fatal opioid overdose: prevention, treatment and harm reduction strategies. Yale Journal of Biology and Medicine, 88(3), 235-245.
5. 5.Proctor, E., Silmere, H., Raghavan, R., Hovmand, P., Aarons, G., Bunger, A., Griffey, R., & Hensley, M. (2011). Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda. Administration and Policy in Mental Health, 38(2), 65-76. https://doi.org/10.1007/s10488-010-0319-7
6. 6.University of Illinois at Chicago. (2024). Chicago Data-driven Opioid Use Disorder Screening, Engagement, Treatment and Planning System. ClinicalTrials.gov. NCT07498322. https://clinicaltrials.gov/study/NCT07498322
7. 7.Volkow, N. D., & Blanco, C. (2021). The changing opioid crisis: development, challenges and opportunities. Molecular Psychiatry, 26(1), 218-233. https://doi.org/10.1038/s41380-020-0661-4
8. 8.Wakeman, S. E., & Barnett, M. L. (2018). Primary care and the opioid-overdose crisis — buprenorphine myths and realities. New England Journal of Medicine, 379(1), 1-4. https://doi.org/10.1056/NEJMp1802741